ERBB2 and breast cancer: TNBC does not express hormone receptors and Her-2, cannot benefit from endocrine therapy and Her-2 targeted therapy, and their pathological characteristics, treatment and prognosis are very different from those of other types of breast cancer, which has attracted much attention (5).